Biotechnology News

April 4, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta presented preclinical results on the use of ganetespib, in melanoma and colorectal cancer at the 103rd Annual Meeting American Association for Cancer Research (AACR).

April 4, 2012

FORT COLLINS, Colo.--(BUSINESS WIRE)--Phase 2 Clinical Trial Results: VEN100 Reduces Antibiotic-Associated Diarrhea by 50% in High-Risk Patients

April 4, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Late-Breaker Clinical Data Presented at AACR 2012 Annual Meeting for BIND-014, Lead Candidate from BIND’s Accurin Platform for Targeted and Programmable Nanomedicines

April 4, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2012 before the market opens on Wednesday, April 25, 2012...

April 4, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--The American Diabetes Association has signed a strategic agreement with Quintiles’ Digital Patient Unit which will provide access to Quintiles’ MediGuard.org medication monitoring service.

April 4, 2012

ROCHESTER, N.Y.--(BUSINESS WIRE)--Georgian Radiology Consultants (Barrie, Ontario) installed new, advanced digital X-ray systems at six imaging clinics that serve more than 360,000 community residents.

April 4, 2012

TUCSON, Ariz., & CAMBRIDGE, Mass.--(BUSINESS WIRE)--The Muscular Dystrophy Association announced today that it has awarded $120,000 to Cambridge, Mass.-based Catabasis Pharmaceuticals as part of a strategic partnership under which the...

April 4, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq: XNPT) announced today that it was awarded U.S. Patent 8,148,414 for “Prodrugs of Methyl Hydrogen Fumarate, Pharmaceutical Compositions Thereof, and Methods of Use.” The term of the...

April 4, 2012

LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (“IMUC” or the “Company”) (OTCBB: IMUC), a clinical-stage biotechnology company that is focused on developing new immune-based products to treat and diagnose cancer, announced today...

April 4, 2012

HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) announced today that its first quarter 2012 financial results will be released before the market opens on Tuesday, May 1, 2012 and will be available on Impax’s Web site at...

April 4, 2012

MINNETONKA, Minn.--(BUSINESS WIRE)--Anulex Technologies, Inc. Receives FDA Clearance for Expanded Indications of fiXate™ Tissue Band.

April 4, 2012

BASKING RIDGE, N.J.--(BUSINESS WIRE)--Ipsen today announced that it has completed the appointment of its nine-member US Leadership Team, tasked with advancing business and commercialization activities for its specialty medicines.

April 4, 2012

DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets....

April 4, 2012

BRISBANE, Calif.--(BUSINESS WIRE)--XDx, Inc., a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high value non-invasive tests to monitor immune status in transplant recipients and...

April 4, 2012

NEW YORK--(BUSINESS WIRE)--The New York Genome Center (NYGC) today announced that it has been selected to receive a generous grant from the Alfred P. Sloan Foundation to help build the infrastructure needed to support a large-scale genome...

April 4, 2012

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) announced today that the Company has submitted to the U.S. Food and Drug Administration (FDA) a complete response to the FDA’s letter regarding the previously announced Full Clinical Hold...

April 4, 2012

SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)--The patented BMB is a single platform which can be utilized from Biomarker Discovery directly to In-Vitro Diagnostics. This approach enables users to optimize efficiency and maximize resources.

April 4, 2012

SYDNEY--(BUSINESS WIRE)--Following the merger of private drug developer Hunter Immunology Limited with Probiomics Limited (ASX: PCC), the merged entity today recommenced trading on the Australian Securities Exchange (ASX).

April 4, 2012

BERLIN--(BUSINESS WIRE)--NOXXON Pharma, a biopharmaceutical company pioneering the development of a new class of proprietary therapeutics called Spiegelmers, today announced that a preclinical study of the SDF-1 inhibiting Spiegelmer NOX-A12...

April 4, 2012

BASEL, Switzerland--(BUSINESS WIRE)--Roche (SIX: RO, ROG; OTCQX: RHHBY) today sent a second letter to shareholders of Illumina, Inc. (NASDAQ: ILMN) urging them to tender their shares into Roche’s increased offer and vote for Roche’s independent...

April 4, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology Announces Pricing of Public Offering

April 3, 2012

NORWALK, Conn.--(BUSINESS WIRE)--The Multiple Myeloma Research Foundation (MMRF) today announced the key study design information and genetic analysis plans for its ongoing, landmark CoMMpass(SM) (Relating Clinical Outcomes in MM to Personal...

April 3, 2012

SANTA ROSA, Calif.--(BUSINESS WIRE)--Sapheon Inc. announced today that Dieter Bielang has joined the company in the position of International Sales Director, Europe. Dieter comes to Sapheon from his position as Vice President, Vascular...

April 3, 2012

SAN ANTONIO--(BUSINESS WIRE)--Joseph F. Woody and Lisa N. Colleran to Join Board of Directors of Parent Company of KCI and LifeCell. Ronald A. Matricaria to Step Down from Board Following Transition Period.

April 3, 2012

LUTZ, Fla.--(BUSINESS WIRE)--CytoDyn Inc. (the "Company") (OTC QB:CYDY), a biotechnology company focused on the development of new therapies for combating infection with immune deficiency virus and other antibody applications, announced today...

April 3, 2012

MORRISVILLE, N.C.--(BUSINESS WIRE)--Furiex will release its first quarter 2012 financial results on Thursday, May 3, 2012, after the market closes. Earnings Call on Friday, May 4, 2012, at 9 a.m. ET.

April 3, 2012

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Codexis, Inc. (Nasdaq:CDXS) announced today that collaborative research conducted by Merck and Codexis scientists to develop a highly efficient, enzyme-based production method for a key intermediate in the...

April 3, 2012

BRUSSELS--(BUSINESS WIRE)--Following the successful completion of a preliminary phase and the enthusiasm shown by its teams and businesses, Alliance Boots will commence the roll-out of its international partnership with the European Organisation...

April 3, 2012

BOSTON--(BUSINESS WIRE)--Pathway Genomics Teams with Harvard Medical School and University of Michigan for NHGRI-Funded Genomic Testing Study

April 3, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that research related to its antibody-drug conjugate (ADC) technology was presented at the 103rd Annual Meeting of the American Association for Cancer Research...

April 3, 2012

MADISON, Wis.--(BUSINESS WIRE)--Global experts address the questions related to near death experiences (NDEs), dying and consciousness during the 11th Annual International Bioethics Forum held April 26-27, 2012 in Madison, Wisconsin

April 3, 2012

MALVERN, Pa.--(BUSINESS WIRE)--TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule Smac mimetic drugs to treat cancer, today announced that new preclinical data on its Smac mimetic drug candidate birinapant (...

April 3, 2012

PARIS--(BUSINESS WIRE)--Cegedim Relationship Management today announced the launch of the new version of its aggregate spend transparency and disclosure compliance solution, AggregateSpend360™, the only solution on the market that supports local...

April 3, 2012

SILVER SPRING, Md.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB:NVLX) and SG Austria bring to light role of Cell-in-a-Box® therapeutic antibody production for clinically important diseases.

April 3, 2012

NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors who purchased Metabolix, Inc.

April 3, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--athenahealth, Inc. (NASDAQ: ATHN), a leading provider of cloud-based practice management, electronic health record (EHR), and care coordination services to medical groups, today named Dr. Abraham Verghese and...

April 3, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens (NYSE:WAG) (NASDAQ:WAG) presented new data last week at the Centers for Disease Control and Prevention’s 2012 National Immunization Conference, providing evidence of the company’s leadership in...

April 3, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Almost half of drug research companies pay between $1 million and $5 million to develop targeted therapeutic technologies that increase the effectiveness of drugs in development

April 3, 2012

MILWAUKEE--(BUSINESS WIRE)--CEO Cynthia (Dohmen) LaConte announced today that the Dohmen Company has acquired BioSoteria, a leading provider of drug safety and risk management services to the biopharmaceutical industry.

April 3, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the field of cancer metabolism, announced today that preclinical data from Agios research were...

April 3, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN), a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function, today sent a third letter to its...

April 3, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals today announced that it received notification from the FDA that the PDUFA date for Lymphoseek®, has been modified to September 10, 2012.

April 3, 2012

MELBOURNE, Australia--(BUSINESS WIRE)--Cancer Therapeutics, a company focused on translating cancer biology research into novel treatments for cancer, today announced positive preclinical results for CTX-0294945 as an adjuvant therapy to the...

April 3, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Knome, Inc. has been selected by Illumina, Inc., (NASDAQ: ILMN) as a partner in the Illumina Genome Network (IGN).

April 3, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Knome, Inc. has continued to expand its scientific advisory board to include respected life sciences expert and industry pioneer, Hugh Y. Rienhoff, Jr., MD.

April 3, 2012

BRUSSELS & ATLANTA--(BUSINESS WIRE)--UCB announced today that the U.S. Food and Drug Administration (FDA) approved Neupro® (Rotigotine Transdermal System) for the treatment of the signs and symptoms of advanced stage idiopathic Parkinson’s...

April 3, 2012

SEVERNA PARK, Md.--(BUSINESS WIRE)--iSonea Ltd. announces that Dr. Ross Macdonald and Dr. Stewart Washer have been appointed to join iSonea’s Board of Directors and Mr. Donal O’Dwyer has been selected as a special advisor to the Board.

April 3, 2012

RALEIGH, N.C.--(BUSINESS WIRE)--ISPE: WHAT:     The ISPE CASA Chapter will hold its 19th Annual Life Sciences Technology Show on Tuesday, April 10 at the PNC Arena (formerly RBC Center) in Raleigh, N.C. This is among the largest one-day...